Skip to main content
. Author manuscript; available in PMC: 2023 Sep 28.
Published in final edited form as: Prog Cardiovasc Dis. 2022 Feb 1;73:48–55. doi: 10.1016/j.pcad.2022.01.005

Figure 3: Meta-regression plots assessing the effect of A) female gender and B) annualized event rate per 1,000 person-years (AER) on the risk ratio associated with polypill for the MACE outcome.

Figure 3:

An increasing proportion of women (slope= −0.017, p=0.002) and lower AER (slope= 0.018, p=0.012) were each associated with greater risk reduction for MACE with the use of polypill. AER, annualized event rate